{"filing":{"accession_number":"0001213900-26-100185","cik":"0001468492","ticker":"HSCSW","company_name":"HeartSciences Inc.","form":"8-K","filing_date":"2026-09-15","report_date":"2026-09-15","primary_document":"ea0305626-8k_heart.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1468492/000121390026100185/ea0305626-8k_heart.htm"},"events":[{"id":33688,"run_id":30988,"accession_number":"0001213900-26-100185","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"HeartSciences issued a press release on September 15, 2026 disclosing financial results for the fiscal first quarter ended July 31, 2026, including operating loss of $2.9 million and net loss of $3.2 million. Although the filing also discusses the proposed Fortitude merger transaction, the Item 2.02 disclosure centers on quarterly financial results and is accompanied by Exhibit 99.1 (the press release), which is the hallmark of an earnings release. The material financial condition—including the shareholders' deficit of $2.0 million and inventory reserve of $0.3 million—makes this disclosure material to investors.","company_name":"HeartSciences Inc.","ticker":"HSCSW","filing_date":"2026-09-15","form":"8-K","submitted_at":null,"items":[{"id":37203,"accession_number":"0001213900-26-100185","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"HeartSciences issued a press release on September 15, 2026 disclosing financial results for the fiscal first quarter ended July 31, 2026, including operating loss of $2.9 million and net loss of $3.2 million. Although the filing also discusses the proposed Fortitude merger transaction, the Item 2.02 disclosure centers on quarterly financial results and is accompanied by Exhibit 99.1 (the press release), which is the hallmark of an earnings release. The material financial condition—including the shareholders' deficit of $2.0 million and inventory reserve of $0.3 million—makes this disclosure material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-15T21:04:42.578015+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":37203,"accession_number":"0001213900-26-100185","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"HeartSciences issued a press release on September 15, 2026 disclosing financial results for the fiscal first quarter ended July 31, 2026, including operating loss of $2.9 million and net loss of $3.2 million. Although the filing also discusses the proposed Fortitude merger transaction, the Item 2.02 disclosure centers on quarterly financial results and is accompanied by Exhibit 99.1 (the press release), which is the hallmark of an earnings release. The material financial condition—including the shareholders' deficit of $2.0 million and inventory reserve of $0.3 million—makes this disclosure material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-15T21:04:42.578015+00:00","company_name":"HeartSciences Inc.","ticker":"HSCSW","filing_date":"2026-09-15"}]}